<DOC>
	<DOCNO>NCT00259532</DOCNO>
	<brief_summary>The purpose project evaluate compare three new method diagnosis , stag , operability evaluation treatment control pancreas cancer . The investigator use contrast-enhanced ultrasound combine gastrointestinal hormone Secretin Cholecystokinin , trigger enzyme production pancreas . The hormones induce increase metabolism thus increase blood flow healthy pancreas tissue , however , tumor tissue . The investigator hope able use effect diagnostically . The patient include also 64-slice-CT order evaluate , increase diagnostic safety reach compare old CT scan method . All patient also examine tumor marker CA 19-9 . Further , investigator examine contrast-enhanced ultrasound contribute information treatment control either surgery medical treatment .</brief_summary>
	<brief_title>Three New Methods Diagnosing Pancreas Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>suspicion cancer pancreas</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>